Isolated REM Sleep without Atonia Is Not Equivalent to REM Sleep Behavior Disorder in Early-Stage Parkinson's Disease.

REM behavior disorder REM sleep without atonia early‐stage Parkinson's disease progression

Journal

Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688

Informations de publication

Date de publication:
26 Apr 2024
Historique:
revised: 08 03 2024
received: 21 09 2023
accepted: 02 04 2024
medline: 26 4 2024
pubmed: 26 4 2024
entrez: 26 4 2024
Statut: aheadofprint

Résumé

In early-stage Parkinson's disease (PD), rapid eye movement (REM) sleep behavior disorder (RBD) predicts poor cognitive and motor outcome. However, the baseline significance and disease evolution associated with isolated REM sleep without atonia (iRWA, ie, enhanced muscle tone during 8.7% of REM sleep, but no violent behavior) are not well understood. The objective is to determine whether iRWA was a mild form of RBD and progressed similarly over time. Participants with early PD (<4 years from medical diagnosis) were included from 2014 to 2021 in a longitudinal study. They underwent interviews and examinations in the motor, cognitive, autonomous, psychiatric, sensory, and sleep domains every year for 4 years along with a video polysomnography and magnetic resonance imaging examination of the locus coeruleus/subcoeruleus complex (LC/LsC) at baseline. The clinical characteristics were compared between groups with normal REM sleep, with iRWA and with RBD, at baseline and for 4 years. Among 159 PD participants, 25% had RBD, 25% had iRWA, and 50% had normal REM sleep. At baseline, the non-motor symptoms were less prevalent and the LC/LsC signal intensity was more intense in participants with iRWA than with RBD. Over 4 years, participants with normal REM sleep and with iRWA had a similar cognitive and motor trajectory, whereas participants with RBD had greater cognitive and motor decline. We demonstrated that iRWA is frequent in early PD, but is not a milder form of RBD. Both groups have distinct baseline characteristics and clinical trajectories. They should be distinguished in clinical routine and research protocols. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Sections du résumé

BACKGROUND BACKGROUND
In early-stage Parkinson's disease (PD), rapid eye movement (REM) sleep behavior disorder (RBD) predicts poor cognitive and motor outcome. However, the baseline significance and disease evolution associated with isolated REM sleep without atonia (iRWA, ie, enhanced muscle tone during 8.7% of REM sleep, but no violent behavior) are not well understood.
OBJECTIVES OBJECTIVE
The objective is to determine whether iRWA was a mild form of RBD and progressed similarly over time.
METHODS METHODS
Participants with early PD (<4 years from medical diagnosis) were included from 2014 to 2021 in a longitudinal study. They underwent interviews and examinations in the motor, cognitive, autonomous, psychiatric, sensory, and sleep domains every year for 4 years along with a video polysomnography and magnetic resonance imaging examination of the locus coeruleus/subcoeruleus complex (LC/LsC) at baseline. The clinical characteristics were compared between groups with normal REM sleep, with iRWA and with RBD, at baseline and for 4 years.
RESULTS RESULTS
Among 159 PD participants, 25% had RBD, 25% had iRWA, and 50% had normal REM sleep. At baseline, the non-motor symptoms were less prevalent and the LC/LsC signal intensity was more intense in participants with iRWA than with RBD. Over 4 years, participants with normal REM sleep and with iRWA had a similar cognitive and motor trajectory, whereas participants with RBD had greater cognitive and motor decline.
CONCLUSIONS CONCLUSIONS
We demonstrated that iRWA is frequent in early PD, but is not a milder form of RBD. Both groups have distinct baseline characteristics and clinical trajectories. They should be distinguished in clinical routine and research protocols. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Identifiants

pubmed: 38666582
doi: 10.1002/mds.29813
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fondation EDF
Organisme : Agence Nationale de la Recherche
Organisme : Société Française de Médecine Esthétique and Energipole
Organisme : Fondation planiol
Organisme : fondation Saint Michel

Informations de copyright

© 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Références

Baker KG, Törk I, Hornung JP, Halasz P. The human locus coeruleus complex: an immunohistochemical and three dimensional reconstruction study. Exp Brain Res 1989;77(2):257–270. https://doi.org/10.1007/bf00274983
García‐Lorenzo D, Longo‐dos Santos C, Ewenczyk C, et al. The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease. Brain 2013;136(7):2120–2129. https://doi.org/10.1093/brain/awt152
Postuma RB, Iranzo A, Hu M, et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain 2019;142(3):744–759. https://doi.org/10.1093/brain/awz030
Anang JB, Gagnon JF, Bertrand JA, et al. Predictors of dementia in Parkinson disease: a prospective cohort study. Neurology 2014;83(14):1253–1260. https://doi.org/10.1212/wnl.0000000000000842
Liu Y, Lawton MA, Lo C, et al. Longitudinal changes in Parkinson's disease symptoms with and without rapid eye movement sleep behavior disorder: the Oxford discovery cohort study. Mov Disord 2021;36(12):2821–2832. https://doi.org/10.1002/mds.28763
Pagano G, De Micco R, Yousaf T, Wilson H, Chandra A, Politis M. REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease. Neurology 2018;91(10):e894–e905. https://doi.org/10.1212/wnl.0000000000006134
Postuma RB, Bertrand JA, Montplaisir J, et al. Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study. Mov Disord 2012;27(6):720–726. https://doi.org/10.1002/mds.24939
Fereshtehnejad SM, Romenets SR, Anang JB, Latreille V, Gagnon JF, Postuma RB. New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol 2015;72(8):863–873. https://doi.org/10.1001/jamaneurol.2015.0703
Otaiku DAI. Distressing dreams and risk of Parkinson's disease: a population‐based cohort study. EClinicalMedicine 2022;48:101474. https://doi.org/10.1016/j.eclinm.2022.101474
Ylikoski A, Martikainen K, Partinen M. Parasomnias and isolated sleep symptoms in Parkinson's disease: a questionnaire study on 661 patients. J Neurol Sci 2014;346(1–2):204–208. https://doi.org/10.1016/j.jns.2014.08.025
Gagnon JF, Bédard MA, Fantini ML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 2002;59(4):585–589. https://doi.org/10.1212/wnl.59.4.585
Stefani A, Gabelia D, Högl B, et al. Long‐term follow‐up investigation of isolated rapid eye movement sleep without Atonia without rapid eye movement sleep behavior disorder: a pilot study. J Clin Sleep Med 2015;11(11):1273–1279. https://doi.org/10.5664/jcsm.5184
Liu Y, Zhang J, Chau SWH, et al. Evolution of prodromal REM sleep behavior disorder to neurodegeneration: a retrospective longitudinal case‐control study. Neurology 2022;99(6):e627–e637. https://doi.org/10.1212/wnl.0000000000200707
Sasai‐Sakuma T, Frauscher B, Mitterling T, et al. Quantitative assessment of isolated rapid eye movement (REM) sleep without atonia without clinical REM sleep behavior disorder: clinical and research implications. Sleep Med 2014;15(9):1009–1015. https://doi.org/10.1016/j.sleep.2014.02.010
Pauline Dodet MH, Leu‐Semenescu S, Corvol J‐C, Lehéricy S, Mangone G, Vidailhet M, Roze E. Isabelle Arnulf sleep disorders in Parkinson's disease, an early and multiple problem. NPJ Parkinsons Dis 2024;10:46.
Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society‐sponsored revision of the unified Parkinson's disease rating scale (MDS‐UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008;23(15):2129–2170. https://doi.org/10.1002/mds.22340
Mattis SBL, Karasu TB. Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karasu TB, eds. Geriatric Psychiatry a Handbook for Psychiatrists and Primary Care Physicians Grune & Stratton. Vol. 77–121. Grune and Stratton: New York; 1976.
Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology 2000;55(11):1621–1626. https://doi.org/10.1212/wnl.55.11.1621
Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53(4):695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
Funkiewiez A, Bertoux M, de Souza LC, Lévy R, Dubois B. The SEA (social cognition and emotional assessment): a clinical neuropsychological tool for early diagnosis of frontal variant of frontotemporal lobar degeneration. Neuropsychology 2012;26(1):81–90. https://doi.org/10.1037/a0025318
Rodriguez‐Blazquez C, Forjaz MJ, Frades‐Payo B, de Pedro‐Cuesta J, Martinez‐Martin P. Independent validation of the scales for outcomes in Parkinson's disease‐autonomic (SCOPA‐AUT). Eur J Neurol 2010;17(2):194–201. https://doi.org/10.1111/j.1468-1331.2009.02788.x
Chaudhuri KR, Sauerbier A, Rojo JM, et al. The burden of non‐motor symptoms in Parkinson's disease using a self‐completed non‐motor questionnaire: a simple grading system. Parkinsonism Relat Disord 2015;21(3):287–291. https://doi.org/10.1016/j.parkreldis.2014.12.031
Lawton M, Hu MT, Baig F, et al. Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' sticks test in patients with Parkinson's disease. Parkinsonism Relat Disord 2016;33:96–101. https://doi.org/10.1016/j.parkreldis.2016.09.023
Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav 1984;32(3):489–502. https://doi.org/10.1016/0031-9384(84)90269-5
Iber CA‐IS, Chesson A, Quan S. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. 1rst ed. Westchester, IL: American Academy of Sleep Medicine; 2007 Revision 2.5 (2018).
Frauscher B, Iranzo A, Gaig C, et al. Normative EMG values during REM sleep for the diagnosis of REM sleep behavior disorder. Sleep 2012;35(6):835–847. https://doi.org/10.5665/sleep.1886
Medicine AAoS. American Academy of sleep medicine. The International Classification of Sleep Disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.
Nobileau A, Gaurav R, Chougar L, et al. Neuromelanin‐sensitive magnetic resonance imaging changes in the locus coeruleus/subcoeruleus complex in patients with typical and atypical parkinsonism. Mov Disord 2023;38(3):479–484. https://doi.org/10.1002/mds.29309
Zhang J, Xu CY, Liu J. Meta‐analysis on the prevalence of REM sleep behavior disorder symptoms in Parkinson's disease. BMC Neurol 2017;17(1):23. https://doi.org/10.1186/s12883-017-0795-4
Dijkstra F, Reyn N, de Bruyn B, et al. REM sleep without atonia and nocturnal body position in prediagnostic Parkinson's disease. Sleep Med 2021;84:308–316. https://doi.org/10.1016/j.sleep.2021.06.011
Nomura T, Inoue Y, Kagimura T, Nakashima K. Clinical significance of REM sleep behavior disorder in Parkinson's disease. Sleep Med 2013;14(2):131–135. https://doi.org/10.1016/j.sleep.2012.10.011
Zimansky L, Muntean ML, Leha A, Mollenhauer B, Trenkwalder C, Sixel‐Döring F. Incidence and progression of rapid eye movement behavior disorder in early Parkinson's disease. Mov Disord Clin Pract 2021;8(4):534–540. https://doi.org/10.1002/mdc3.13168
Rahayel S, Gaubert M, Postuma RB, et al. Brain atrophy in Parkinson's disease with polysomnography‐confirmed REM sleep behavior disorder. Sleep 2019;42(6):zsz062. https://doi.org/10.1093/sleep/zsz062
Kotagal V, Albin RL, Müller ML, Koeppe RA, Chervin RD, Frey KA, Bohnen NI. Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Ann Neurol 2012;71(4):560–568. https://doi.org/10.1002/ana.22691
Arnaldi D, Morbelli S, Brugnolo A, et al. Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD. Parkinsonism Relat Disord 2016;29:47–53. https://doi.org/10.1016/j.parkreldis.2016.05.031
Sommerauer M, Fedorova TD, Hansen AK, et al. Evaluation of the noradrenergic system in Parkinson's disease: an 11C‐MeNER PET and neuromelanin MRI study. Brain 2018;141(2):496–504. https://doi.org/10.1093/brain/awx348
Boissard R, Fort P, Gervasoni D, Barbagli B, Luppi PH. Localization of the GABAergic and non‐GABAergic neurons projecting to the sublaterodorsal nucleus and potentially gating paradoxical sleep onset. Eur J Neurosci 2003;18(6):1627–1639. https://doi.org/10.1046/j.1460-9568.2003.02861.x
Braak E, Sandmann‐Keil D, Rüb U, et al. Alpha‐synuclein immunopositive Parkinson's disease‐related inclusion bodies in lower brain stem nuclei. Acta Neuropathol 2001;101(3):195–201. https://doi.org/10.1007/s004010000247
Iranzo A, Tolosa E, Gelpi E, et al. Neurodegenerative disease status and post‐mortem pathology in idiopathic rapid‐eye‐movement sleep behaviour disorder: an observational cohort study. Lancet Neurol 2013;12(5):443–453. https://doi.org/10.1016/s1474-4422(13)70056-5
McKenna D, Peever J. Degeneration of rapid eye movement sleep circuitry underlies rapid eye movement sleep behavior disorder. Mov Disord 2017;32(5):636–644. https://doi.org/10.1002/mds.27003
Mariotti P, Quaranta D, di Giacopo R, et al. Rapid eye movement sleep behavior disorder: a window on the emotional world of Parkinson disease. Sleep 2015;38(2):287–294. https://doi.org/10.5665/sleep.4416
Bugalho P, Paiva T. Dream features in the early stages of Parkinson's disease. J Neural Transm (Vienna) 2011;118(11):1613–1619. https://doi.org/10.1007/s00702-011-0679-5
Cygan F, Oudiette D, Leclair‐Visonneau L, Leu‐Semenescu S, Arnulf I. Night‐to‐night variability of muscle tone, movements, and vocalizations in patients with REM sleep behavior disorder. J Clin Sleep Med 2010;6(6):551–555.
Puligheddu M, Figorilli M, Congiu P, et al. Quantification of REM sleep without atonia: a review of study methods and meta‐analysis of their performance for the diagnosis of RBD. Sleep Med Rev 2023;68:101745. https://doi.org/10.1016/j.smrv.2023.101745
Videnovic A, Marlin C, Alibiglou L, Planetta PJ, Vaillancourt DE, Mackinnon CD. Increased REM sleep without atonia in Parkinson disease with freezing of gait. Neurology 2013;81(12):1030–1035. https://doi.org/10.1212/WNL.0b013e3182a4a408

Auteurs

Pauline Dodet (P)

Service des Pathologies du Sommeil et Centre de Référence National des Narcolepsies et Hypersomnies rares, Assistance Publique-Hôpitaux de Paris-Sorbonne (AP-HP-Sorbonne), Hôpital la Pitié-Salpêtrière, Paris, France.
Sorbonne University, Paris Brain Institute (ICM), Inserm, CNRS, Paris, France.

Marion Houot (M)

Center of Excellence of Neurodegenerative Disease (CoEN), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
Department of Neurology, Institute of Memory and Alzheimer's Disease (IM2A), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
Assistance Publique Hôpitaux de Paris, Department of Neurology, Clinical Investigation Centre Neuroscience, Pitié-Salpêtrière Hospital, Paris, France.

Smaranda Leu-Semenescu (S)

Service des Pathologies du Sommeil et Centre de Référence National des Narcolepsies et Hypersomnies rares, Assistance Publique-Hôpitaux de Paris-Sorbonne (AP-HP-Sorbonne), Hôpital la Pitié-Salpêtrière, Paris, France.
Sorbonne University, Paris Brain Institute (ICM), Inserm, CNRS, Paris, France.

Rahul Gaurav (R)

Sorbonne University, Paris Brain Institute (ICM), Inserm, CNRS, Paris, France.
Department of Neuroradiology, Assistance Publique Hôpitaux de Paris, Hôpital Pitié -Salpêtrière, Paris, France.

Graziella Mangone (G)

Assistance Publique Hôpitaux de Paris, Department of Neurology, Clinical Investigation Centre Neuroscience, Pitié-Salpêtrière Hospital, Paris, France.

Jean-Christophe Corvol (JC)

Sorbonne University, Paris Brain Institute (ICM), Inserm, CNRS, Paris, France.
Center of Excellence of Neurodegenerative Disease (CoEN), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
Assistance Publique Hôpitaux de Paris, Department of Neurology, Clinical Investigation Centre Neuroscience, Pitié-Salpêtrière Hospital, Paris, France.

Stéphane Lehéricy (S)

Sorbonne University, Paris Brain Institute (ICM), Inserm, CNRS, Paris, France.
Department of Neuroradiology, Assistance Publique Hôpitaux de Paris, Hôpital Pitié -Salpêtrière, Paris, France.

Marie Vidailhet (M)

Sorbonne University, Paris Brain Institute (ICM), Inserm, CNRS, Paris, France.
Center of Excellence of Neurodegenerative Disease (CoEN), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
Assistance Publique Hôpitaux de Paris, Department of Neurology, Clinical Investigation Centre Neuroscience, Pitié-Salpêtrière Hospital, Paris, France.

Emmanuel Roze (E)

Sorbonne University, Paris Brain Institute (ICM), Inserm, CNRS, Paris, France.
Center of Excellence of Neurodegenerative Disease (CoEN), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
Assistance Publique Hôpitaux de Paris, Department of Neurology, Clinical Investigation Centre Neuroscience, Pitié-Salpêtrière Hospital, Paris, France.

Isabelle Arnulf (I)

Service des Pathologies du Sommeil et Centre de Référence National des Narcolepsies et Hypersomnies rares, Assistance Publique-Hôpitaux de Paris-Sorbonne (AP-HP-Sorbonne), Hôpital la Pitié-Salpêtrière, Paris, France.
Sorbonne University, Paris Brain Institute (ICM), Inserm, CNRS, Paris, France.

Classifications MeSH